This content is in French.
Photobiomodulation: A breakthrough in the treatment of recurrent labial herpes
20 novembre 2024
Recurrent labial herpes (RLH), caused by the
herpes simplex virus type 1 (HSV-1), affects 20% to 40% of young adults.
Although often self-limiting, RLH causes bothersome symptoms such as pain and
vesicular lesions. The standard treatment, based on the application of
acyclovir cream, is limited by its poor penetration into subcutaneous tissues
and partial efficacy, prompting increasing interest in complementary therapies.
This study investigates the use of photobiomodulation (PBMT) as an adjunct to
conventional treatment.
To assess the effectiveness of PBMT as a complement to acyclovir, 22 patients with RLH were selected and divided into two groups:
Can Photobiomodulation be considered for the treatment of labial herpes?
To assess the effectiveness of PBMT as a complement to acyclovir, 22 patients with RLH were selected and divided into two groups:
Sign in to read the rest
Reserved for healthcare professionals, free registration.
Scientific reference
Seyyedi, S. A., et al. (2024). Efficacy of adjuvant photobiomodulation therapy in recurrent herpes labialis, a randomized clinical trial study. Photodiagnosis and Photodynamic Therapy, 49, 104282
View the source
